PLX Earnings — Protalix BioTherapeutics, Inc. Common Stock Post-ER Performance | BigEarnings
PLX — Protalix BioTherapeutics, Inc. Common Stock
XASE · Healthcare · Biotechnology
Price$2.10
Market Cap$170.8M
P/E11.1
52W Range$1.32 – $3.19
About Protalix BioTherapeutics, Inc. Common Stock
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
